Publishing research using ab50850? Please let us know so that we can cite the reference in this datasheet.

ab50850 has been referenced in 5 publications.

  • Almuzzaini B  et al. In ß-actin knockouts, epigenetic reprogramming and rDNA transcription inactivation lead to growth and proliferation defects. FASEB J 30:2860-73 (2016). PubMed: 27127100
  • Geiger R  et al. L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. Cell 167:829-842.e13 (2016). Human . PubMed: 27745970
  • Almuzzaini B  et al. Nuclear myosin 1 contributes to a chromatin landscape compatible with RNA polymerase II transcription activation. BMC Biol 13:35 (2015). PubMed: 26044184
  • Sarshad AA  et al. Glycogen synthase kinase (GSK) 3ß phosphorylates and protects nuclear myosin 1c from proteasome-mediated degradation to activate rDNA transcription in early G1 cells. PLoS Genet 10:e1004390 (2014). Human . PubMed: 24901984
  • Sarshad A  et al. Nuclear myosin 1c facilitates the chromatin modifications required to activate rRNA gene transcription and cell cycle progression. PLoS Genet 9:e1003397 (2013). Human . PubMed: 23555303

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"